## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `pt-141-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/pt-141-post-surgery/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-post-surgery/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-post-surgery/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-post-surgery/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-post-surgery/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `pt-141-post-surgery` v2 · content_hash `017d04c9626a6750…` · thread_head genesis · 22 DIVs - **thesis (c1):** Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD. - c2 [human/active] No dedicated randomized human trials examine PT-141 specifically in post-surgical populations. - c3 [mechanistic/active] Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits. - c4 [anecdotal/active] User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-post-surgery/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-post-surgery/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `pt-141-post-surgery` - **title:** PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery - **url:** https://miscsubjects.com/a/pt-141-post-surgery - **register:** source_ledger - **updated:** 2026-07-17T02:41:09.189Z - **tags:** peptide, matrix ## Body ## What's breaking down Post-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period. ## Why PT-141 might help you PT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain. 1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly. 2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms. 3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits. ## How these fit together Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - **PT-141** → sexual / CNS arousal ## What the evidence actually shows Human data comes primarily from trials in hypoactive sexual desire disorder (HSDD). Two Phase 3 randomized controlled trials (BMT-301 and BMT-302) enrolled over 1,200 premenopausal women and tested subcutaneous bremelanotide 1.75 mg as-needed versus placebo. These showed statistically significant improvements in sexual desire scores and reduced distress compared to placebo (human tier). A long-term open-label extension followed participants for up to 18 months and reported sustained effects with manageable side effects in completers (human tier). Earlier smaller studies measured physiological arousal via vaginal pulse amplitude after erotic stimuli and found greater increases with bremelanotide than placebo in healthy women and those with arousal disorder (human tier, small n). No dedicated human trials specifically examine PT-141 after surgery. Mentions of post-prostatectomy use appear in clinical discussion articles but lack controlled data (anecdotal/mechanistic tier). Animal studies demonstrate melanocortin agonism increasing sexual behaviors in rodents via hypothalamic pathways (preclinical tier). These do not directly model human post-surgical states. Reddit anecdotes describe subjective increases in arousal or desire after injection, with onset in 1-6 hours and variable duration, alongside reports of nausea or flushing (anecdotal tier). X posts echo similar user experiences of heightened motivation but remain self-reported without controls. ## What scientists say Researchers describe bremelanotide as a nonselective melanocortin receptor agonist with primary action at MC4R in the medial preoptic area of the hypothalamus, leading to increased dopamine release in reward and motivation circuits (mechanistic tier from reviews). This central mechanism differentiates it from peripheral vasodilators. Scientists note the absence of large post-surgical human datasets and emphasize that approved use remains limited to HSDD in premenopausal women. ## What people say on Reddit Users in peptide communities report trying PT-141 for libido concerns that emerged or persisted after procedures. Common themes include noticeable waves of arousal within hours of dosing and effects lasting into the next day for some. Side-effect mentions frequently include transient nausea, flushing, or headache. Experiences vary widely, with some noting no effect on first use. ## What people say on X Posts reference personal use for arousal enhancement, often describing rapid onset of sexual thoughts or responsiveness. Timing relative to activity and individual dosing experiments appear frequently. Side-effect discussions mirror Reddit patterns. No large verified threads or expert threads dominate recent activity. ## What we do not know Direct evidence for PT-141 in post-surgical populations is absent from controlled human trials. Long-term effects on neural repair pathways after surgery remain unstudied. Interactions with common post-operative medications or healing timelines lack specific data. Optimal timing relative to surgical recovery stages is unknown. ## Safety and limits Reported effects in trials include nausea, flushing, and injection-site reactions, with most described as mild to moderate (human tier). The compound carries a boxed warning for blood-pressure increases in its approved formulation. Individual responses differ, and self-experimentation carries unknown risks outside monitored settings. All information here is for research discussion only; consult qualified professionals for personal health decisions. ## Claims (4) - **c1** [human w=0.8] Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD. - who_claims: grok/grok-4.3 - sources: s1 - **c2** [human w=0.8] No dedicated randomized human trials examine PT-141 specifically in post-surgical populations. - who_claims: grok/grok-4.3 - sources: s2 - **c3** [mechanistic w=0.3] Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits. - who_claims: grok/grok-4.3 - sources: s3 - **c4** [anecdotal w=0.3] User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea. - who_claims: grok/grok-4.3 - sources: s4 ## Voxel graph (4 atoms · 8 edges) - full graph: https://miscsubjects.com/api/articles/pt-141-post-surgery/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (4) - chain valid: yes · head: `63b723640f12cc82` ### s1 · clinical_trial · ok - title: Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder - url: https://clinicaltrials.gov/study/NCT01382719 - summary: Phase 3 trial details supporting HSDD efficacy data. - quote: This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide... - claim_ids: c1 - hash: `b37ba9f623c01df7` ### s2 · other · ok - title: Can the PT-141 Peptide Improve Low Libido After Prostate Surgery? - url: https://www.bostonmedicalgroup.com/pt-141-low-libido-after-prostate-surgery/ - summary: Clinical discussion noting post-surgery context but no new trial data. - quote: In this article, we'll explore whether PT-141 for low libido may help men regain sexual desire... - claim_ids: c2 - hash: `e38ee0c5739b289b` ### s3 · pubmed · ok - title: The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder - url: https://pubmed.ncbi.nlm.nih.gov/33455598/ - summary: Mechanism review detailing CNS action. - quote: Bremelanotide may affect female sexual desire by activating presynaptic MC4Rs on neurons in the mPOA of the hypothalamus, leading to increased release of DA. - claim_ids: c3 - hash: `f1b595db88fc864c` ### s4 · reddit · ok - title: PT-141 Major Success! - url: https://www.reddit.com/r/Peptides/comments/1f9yows/pt141_major_success/ - summary: Example anecdotal report of timing and effects. - quote: The effect comes on about 2 hours after injection and goes on strongly for at least 18 hours... - claim_ids: c4 - hash: `63b723640f12cc82` ## Provenance (2 model passes) - chain valid: yes · head: `eb64b4e74da8b513` - write · grok/grok-4.3 · 2026-06-30T01:11 · hash `8cde3da0f7d9` - voxel_divide · owner · 2026-07-17T02:41 · hash `eb64b4e74da8` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/pt-141-post-surgery/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/pt-141-post-surgery/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-post-surgery","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-post-surgery|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-post-surgery|tier|assertion` - **iMessage ask:** `pt-141-post-surgery|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `pt-141-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-post-surgery/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*